6.2 Non-Adherence Risk Factors

Nonadherence is one of the most common—and most misunderstood—risk factors affecting older adults’ outcomes. For GERO-BC Domain I risk identification (I-B-2), you must recognize who is likely to miss doses, abandon therapies, or follow only part of a plan, then connect that risk to assessment and care planning. Avoid the outdated label “noncompliant,” which implies willful defiance. Nonadherence better reflects a gap between the agreed plan and what happens in real life—usually for understandable reasons.

Why Adherence Risk Is High in Gerontological Practice

Older adults often juggle multiple chronic conditions, specialists, and pharmacies. Aging changes (vision, dexterity, cognition, swallowing), fixed incomes, and caregiver dependence multiply barriers. Missed therapy elevates risk for heart failure exacerbation, stroke, hyperglycemia emergencies, COPD flares, transplant rejection, and preventable hospitalization.

Adherence risk identification is preventive assessment: find the barrier before an adverse event proves it.

Intentional vs Unintentional Nonadherence

Clinical pearl: An older adult who “forgets” antihypertensives but never forgets analgesics may be signaling intentional prioritization or side-effect avoidance, not pure memory failure. Ask curiously, not accusingly.

Major Risk Factor Domains

1. Regimen complexity and polypharmacy

Risk rises with:

• Multiple daily dosing times (BID/TID/QID vs once daily)
• Many separate pills versus combination products when appropriate
• “Take with food / take on empty stomach / separate from calcium” rules that conflict
• PRN stacks layered onto scheduled meds
• Frequent regimen changes after hospitalizations without teach-back

Polypharmacy (commonly discussed as ≥5 medications) increases both unintentional errors and intentional rationing. High-risk transitions—hospital discharge, new oxygen, new insulin—deserve intensified adherence risk assessment.

2. Cognitive and sensory barriers

3. Health literacy, language, and education gaps

Low health literacy predicts misunderstanding of indication, dose, and warning signs. Limited English proficiency without professional interpreters produces polite nodding without comprehension. Numeric literacy gaps impair insulin titration, warfarin diet teaching, and taper schedules.

Red flags: cannot name medicines or why they are taken; reads label aloud incorrectly; family answers all questions; forms left blank; anxiety when asked to teach-back.

4. Cost and social determinants

Cost-related nonadherence is extremely common on fixed incomes:

• Stretching pills (“every other day”)
• Skipping the “less important” drug (often preventives)
• Choosing food/rent over prescriptions
• Avoiding specialist copays and lab monitoring required for safe therapy

Transportation gaps, rural pharmacy deserts, caregiver unavailability, and unstable housing also sabotage adherence even when motivation is high.

5. Beliefs, culture, side effects, and trust

Intentional nonadherence often follows:

• Prior adverse effects (bleed on anticoagulant, dizziness on antihypertensive, GI upset on metformin)
• Belief that “I feel fine, so I don’t need it”
• Stigma (psychiatric meds, HIV therapy, incontinence drugs)
• Distrust after rushed encounters or conflicting clinician advice
• Preference for herbal products that interact with prescribed drugs

Do not argue first. Elicit the story: What concerns you about this medicine? What happens when you take it? What would make this plan workable for you?

6. Care system and clinician factors

Risk is not only “patient-sided.” Fragmented care, conflicting instructions from multiple prescribers, 15-minute visits, unreadable after-visit summaries, and lack of med reconciliation after discharge create system-generated nonadherence.

Assessing Adherence Risk Without Blame

Use normalizing language:

• “Many people find it hard to take so many medicines. How has it been for you?”
• “In the last week, how many doses do you think you missed?”
• “Which medicines feel most important to you—and which cause problems?”

Practical assessment methods

Screen for depression, cognition, and SDOH whenever adherence repeatedly fails. Persistent “nonadherence” is an assessment failure until barriers are mapped.

Barrier-Matched Interventions

Risk identification should drive specific interventions:

1. Complexity — deprescribe when safe; align dosing times; once-daily options; blister packs; combination pills if appropriate.
2. Forgetfulness — pill organizers, phone alarms, med sync to one pharmacy pickup day, caregiver cueing.
3. Cost — 90-day supplies, formulary alternatives, discount programs, social work/pharmacy assistance; never assume Medicare Part D eliminates gaps.
4. Literacy/language — plain language, teach-back, teach-to-goal, professional interpreter, pictogram schedules.
5. Sensory/motor — large-print labels, easy-open caps (when safe), liquid/crushable forms if appropriate, OT for adaptive devices.
6. Beliefs/side effects — shared decisions, address myths, adjust agents causing harm, document informed refusal when capacity is intact.
7. Cognition — simplify to essential meds; supervised administration; home health; locked storage if diversion/double-dosing risk.
8. Transitions — discharge med reconciliation with teach-back; follow-up call within days; updated med list to PCP and pharmacy.

Linking adherence risk to safety

Nonadherence risk co-travels with fall risk (skipped antihypertensives then overcatch-up dosing), hypoglycemia (inconsistent insulin/meals), and exploitation (caregiver withholding meds). Document concrete barriers and the plan you initiated.

Exam Focus

Expect items that present unexplained poor control (A1C, BP, INR) and ask for the most likely adherence barrier or the best next assessment question. Choose options that identify cost, complexity, literacy, cognition, or side-effect fear over punitive labels. The correct nursing move matches the barrier rather than simply “re-educating” with the same pamphlet.